Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2003 2
2005 3
2006 1
2014 2
2022 2
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Etiopathogenesis of chronic kidney disease-associated pruritus: putting the pieces of the puzzle together.
Molina P, Ojeda R, Blanco A, Alcalde G, Prieto-Velasco M, Aresté N, Buades JM, Simó VE, Goicoechea M, Pérez-Morales RE, Sánchez-Álvarez E, Sánchez-Villanueva R, Montesa M, Arenas MD. Molina P, et al. Among authors: areste n. Nefrologia (Engl Ed). 2023 Jan-Feb;43(1):48-62. doi: 10.1016/j.nefroe.2023.03.015. Epub 2023 May 10. Nefrologia (Engl Ed). 2023. PMID: 37173258 Free article. Review.
Humoral response after the fourth dose of the SARS-CoV-2 vaccine in the CKD spectrum: a prespecified analysis of the SENCOVAC study.
Quiroga B, Soler MJ, Ortiz A, Jarava Mantecón CJ, Gomes Pérez VO, Bordils A, Lacueva J, Marin Franco AJ, Delgado Conde P, Muñoz Ramos P, Calderón González C, Cazorla López JM, Sanchez-Rodriguez J, Sánchez Horrillo A, Monzón Vázquez TR, Leyva A, Rojas J, Gansevoort RT, de Sequera P; SENCOVAC collaborative network. Quiroga B, et al. Nephrol Dial Transplant. 2023 Mar 31;38(4):969-981. doi: 10.1093/ndt/gfac307. Nephrol Dial Transplant. 2023. PMID: 36423334
Loss of humoral response 3 months after SARS-CoV-2 vaccination in the CKD spectrum: the multicentric SENCOVAC study.
Quiroga B, Soler MJ, Ortiz A, Bernat A, Muñoz Díaz AB, Jarava Mantecón CJ, Gómez Pérez VO, Calderón González C, Cervienka M, Mazuecos A, Cazorla JM, Carnerero Di Riso M, Martínez S, Ortega Diaz M, Lucena Valverde R, Sánchez Márquez MG, Lancho Novillo C, González Parra E, Gracia-Iguacel C, Rodrigo De Tomas MT, Aguilar Cervera MC, Giorgi M, Muñoz Ramos P, Macías Carmona N, Toapanta N, Cigarrán S, Ruiz San Millán JC, Santana Estupiñán R, Crespo M, Villacorta Linaza B, Jimeno Martín MI, Rodríguez-Osorio Jiménez L, Soriano S, González Ferri D, Pizarro Sánchez MS, Yugueros A, Leyva A, Rojas J, Gansevoort RT, de Sequera P; SENCOVAC collaborative network. Quiroga B, et al. Nephrol Dial Transplant. 2022 Apr 25;37(5):994-999. doi: 10.1093/ndt/gfac007. Nephrol Dial Transplant. 2022. PMID: 35022757 Free PMC article. No abstract available.
Anti-Spike antibodies 3 months after SARS-CoV-2 mRNA vaccine booster dose in patients on hemodialysis: the prospective SENCOVAC study.
Quiroga B, Soler MJ, Ortiz A, Jaravaca Mantecón CJ, Nava Pérez N, Serra Martín M, Sato Y, Marin Franco AJ, Pazmiño Zambrano DF, Lucena Valverde R, Ortega Diaz M, Calderón González C, Cazorla López JM, Pereira M, González Parra E, Sánchez Horrillo A, Sánchez González C, Toapanta N, Cigarrán Guldris S, Sánchez Hernández R, Pizarro Sánchez S, Muñiz Rincón M, Garcia-Fernández N, Blanco Castro N, Collantes Mateo R, Quiroz Morales MA, Escamilla-Cabrera B, Berdud Godoy I, Gil-Casares Casanova B, Leyva A, Rojas J, Gansevoort RT, de Sequera P; SENCOVAC collaborative network. Quiroga B, et al. Clin Kidney J. 2022 Jul 26;15(10):1856-1864. doi: 10.1093/ckj/sfac169. eCollection 2022 Oct. Clin Kidney J. 2022. PMID: 36147708 Free PMC article.
Prevalence and severity of pruritus in Spanish patients with chronic kidney disease and impact on quality of life: a cross-sectional study.
Aresté N, Sanchez-Alvarez JE, Prieto-Velasco M, Molina P, Esteve-Simó V, Ojeda R, Buades JM, Goicoechea M, Sanchez-Villanueva R, Bezhold GA, Pérez-Morales RE, Santos AB, Peiró-Jordan R, Arenas MD; Pruritus Week Group. Aresté N, et al. Clin Kidney J. 2023 Mar 23;16(6):1035-1037. doi: 10.1093/ckj/sfac246. eCollection 2023 Jun. Clin Kidney J. 2023. PMID: 37260996 Free PMC article. No abstract available.
Perception of Spanish nephrologists on an old unsolved problem: Pruritus associated with chronic kidney disease (CKD-aP).
Goicoechea M, Arenas-Jimenez MD, Areste N, Perez-Morales RE, Esteve V, Sanchez-Alvarez E, Alcalde Bezhold G, Blanco A, Sanchez-Villanueva R, Molina P, Ojeda R, Prieto-Velasco M, Manuel Buades J. Goicoechea M, et al. Among authors: areste n. Nefrologia (Engl Ed). 2023 Jan-Feb;43(1):102-110. doi: 10.1016/j.nefroe.2023.03.012. Epub 2023 Apr 15. Nefrologia (Engl Ed). 2023. PMID: 37069038 Free article.
Treatment of Chronic Heart Failure in Advanced Chronic Kidney Disease: The HAKA Multicenter Retrospective Real-World Study.
Quiroga B, Ortiz A, Núñez S, Kislikova M, González Sanchidrián S, Broseta JJ, Albines ZS, Escamilla Cabrera B, Rivero Viera Y, Rodriguez Santarelli D, Salanova Villanueva L, Lopez Rodriguez F, Cancho Castellano B, Ibáñez Cerezon M, Gutierrez Rivas CP, Aresté N, Campos Gutiérrez B, Ródenas Gálvez A, Glucksmann Pizá MC, Balda Manzanos S, Soldevila A, Rodríguez Gayo L, Moral Berrio E, Ortega Diaz M, Beltrán Catalán S, Puente García A, Ángel Rojas M, Sosa Barrios RH, Santana Zapatero H, Rangel Hidalgo G, Martinez Canet AM, Díez J; Cardiorenal Medicine Group (CaReSEN) of the Spanish Society of Nephrology. Quiroga B, et al. Among authors: areste n. Cardiorenal Med. 2024;14(1):202-214. doi: 10.1159/000538030. Epub 2024 Apr 3. Cardiorenal Med. 2024. PMID: 38513622 Free article.
Vascular calcification in the uremic patient: a cardiovascular risk?
Salgueira M, del Toro N, Moreno-Alba R, Jiménez E, Aresté N, Palma A. Salgueira M, et al. Among authors: areste n. Kidney Int Suppl. 2003 Jun;(85):S119-21. doi: 10.1046/j.1523-1755.63.s85.28.x. Kidney Int Suppl. 2003. PMID: 12753281 Free article. Clinical Trial.
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival--an analysis of data from the ERA-EDTA Registry.
Spithoven EM, Kramer A, Meijer E, Orskov B, Wanner C, Abad JM, Aresté N, de la Torre RA, Caskey F, Couchoud C, Finne P, Heaf J, Hoitsma A, de Meester J, Pascual J, Postorino M, Ravani P, Zurriaga O, Jager KJ, Gansevoort RT; ERA-EDTA Registry; EuroCYST Consortium; WGIKD. Spithoven EM, et al. Among authors: areste n. Nephrol Dial Transplant. 2014 Sep;29 Suppl 4(Suppl 4):iv15-25. doi: 10.1093/ndt/gfu017. Nephrol Dial Transplant. 2014. PMID: 25165182 Free PMC article.
Analysis of data from the ERA-EDTA Registry indicates that conventional treatments for chronic kidney disease do not reduce the need for renal replacement therapy in autosomal dominant polycystic kidney disease.
Spithoven EM, Kramer A, Meijer E, Orskov B, Wanner C, Caskey F, Collart F, Finne P, Fogarty DG, Groothoff JW, Hoitsma A, Nogier MB, Postorino M, Ravani P, Zurriaga O, Jager KJ, Gansevoort RT; ERA-EDTA Registry; EuroCYST Consortium; WGIKD; EuroCYST Consortium; WGIKD. Spithoven EM, et al. Kidney Int. 2014 Dec;86(6):1244-52. doi: 10.1038/ki.2014.120. Epub 2014 May 14. Kidney Int. 2014. PMID: 24827775 Free article.
16 results